Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/14/2013 | WO2012172346A3 Treating respiratory conditions |
03/14/2013 | WO2012172344A3 Treating conditions associated with sepsis |
03/14/2013 | WO2012170842A3 Peptide for protection of allergic respiratory disorders |
03/14/2013 | WO2012168344A8 BINDING COMPOUNDS TO HUMAN β1-ADRENORECEPTOR (β1-AR) AND THEIR USE IN THE MEASUREMENT OF AUTO-ANTI-βA1-AR ANTIBODIES |
03/14/2013 | WO2012166215A3 Membrane template synthesis of microtube engines |
03/14/2013 | WO2012153187A3 Markers for cancer prognosis and therapy and methods of use |
03/14/2013 | WO2012153186A3 Monoclonal antibodies to epcam-icd and methods for detecting epithelial cancer cells |
03/14/2013 | WO2012150503A3 Glu-glp-1 dual agonist signaling-selective compounds |
03/14/2013 | WO2012149076A3 Method and apparatus for determination of system parameters for reducing crude unit corrosion |
03/14/2013 | WO2012135854A3 T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2 |
03/14/2013 | WO2012129164A3 Biosensor |
03/14/2013 | WO2012115820A3 Biomarker panels, diagnostic methods and test kits for ovarian cancer |
03/14/2013 | WO2012103124A9 Accelerated mixed gas integrity testing of porous materials |
03/14/2013 | WO2012076553A3 Biomarkers and parameters for hypertensive disorders of pregnancy |
03/14/2013 | WO2012052074A3 Novel biomarkers of liver cancer |
03/14/2013 | WO2012012527A8 Method for linking point of care rapid diagnostic testing results to laboratory-based methods |
03/14/2013 | WO2011147274A9 Detection method for 305 fertility-associated sperm localization proteins expressed in human testis and epididymis |
03/14/2013 | US20130067608 Colon cancer targets and uses thereof |
03/14/2013 | US20130067603 Sperm-specific cation channel, catsper4, and uses therefor |
03/14/2013 | US20130066252 Method for diagnosis for multiple sclerosis involving anti1-receptor antibody |
03/14/2013 | US20130066234 Vessel for blood sampling |
03/14/2013 | US20130066088 Methods for obtaining high-yielding oil palm plants |
03/14/2013 | US20130066052 Ucp4 |
03/14/2013 | US20130065945 Nlk as a marker for diagnosis of liver cancer and as a therapeutic agent thereof |
03/14/2013 | US20130065928 Biomarkers for pi3k-driven cancer |
03/14/2013 | US20130065887 Treatment of Cancer with Dopamine Receptor Antagonists |
03/14/2013 | US20130065866 Dentinal drug delivery composition and screening method |
03/14/2013 | US20130065852 Analysis of sulfated polysaccharides |
03/14/2013 | US20130065836 Biomarker for gastric cancer |
03/14/2013 | US20130065835 Prognostic tests for development of dermal stretch marks and implications for the preventative treatment thereof |
03/14/2013 | US20130065785 Prognosis of oesophageal and gastro-oesophageal junctional cancer |
03/14/2013 | US20130065782 Renal Cell Carcinoma Biomarkers and Uses Thereof |
03/14/2013 | US20130065779 Method and reagent for diagnosis and/or evaluation of progression of graft-versus-host disease |
03/14/2013 | US20130065775 Methods for diagnosing skin diseases |
03/14/2013 | US20130065773 Microfluidic Device and Methods of Using Same |
03/14/2013 | US20130065325 Zwitterionic reagents |
03/14/2013 | US20130065324 Immunoassay apparatus incorporating microfluidic channel |
03/14/2013 | US20130065323 Detection of Synthetic Cannabinoids |
03/14/2013 | US20130065322 Radioimmunoassay with a 96-Welled Micro-plate |
03/14/2013 | US20130065319 Photoconductive sensor materials for detection of explosive vapor |
03/14/2013 | US20130065317 Sample analyzer |
03/14/2013 | US20130065315 Apparatus and Method for Handling Fluids for Analysis |
03/14/2013 | US20130065258 Colorectal cancer marker galectin, method for analyzing galectin concentration in blood sample, and kit for detecting colorectal cancer marker galectin |
03/14/2013 | US20130065257 Enzyme-logic biosensing |
03/14/2013 | US20130065256 Assay system |
03/14/2013 | US20130065255 Biomarker to Measure Drug Efficacy in Enteropathic Disease |
03/14/2013 | US20130065254 Novel epigenetic mechanisms related to dna damage and aging |
03/14/2013 | US20130065253 Detection system and uses therefor |
03/14/2013 | US20130065252 Compositions and methods for detecting autoantibodies |
03/14/2013 | US20130065251 Method and system for determination of molecular interaction parameters |
03/14/2013 | US20130065250 Kit and Method for Detecting Porous Dental Hydroxyapatite |
03/14/2013 | US20130065248 Reagents and methods for sirtuin capture |
03/14/2013 | US20130065247 Methods of diagnosing latent and active malignancies |
03/14/2013 | US20130065246 Method for diagnosing melanocytic proliferations |
03/14/2013 | US20130065245 Device |
03/14/2013 | US20130065242 Methods for diagnosing, prognosing and treating muscular dystrophy |
03/14/2013 | US20130065240 Culture medium, method for culturing salmonella and e. coli and method for detecting salmonella and e. coli |
03/14/2013 | US20130065239 Diagnostic method for detecting acute kidney injury using heat shock protein 72 as a sensitive biomarker |
03/14/2013 | US20130065238 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
03/14/2013 | US20130065237 Novel mixtures for assaying nucleic acid, novel method of assaying nucleic acid with the use of the same and nucleic acid probe to be used therefor |
03/14/2013 | US20130065235 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds |
03/14/2013 | US20130065226 Method of determining dose and administration of statin |
03/14/2013 | US20130065221 Hmgb1 and anti-hmgb1 antibodies for the prognostic of neurological disorders |
03/14/2013 | US20130065220 Method of rapidly detecting microorganisms using nanoparticles |
03/14/2013 | US20130064940 Methods for testing milk |
03/14/2013 | US20130064881 Compositions and methods for treating prostate cancer |
03/14/2013 | US20130064845 Bacterial vaccine components from staphylococcus aureus and uses thereof |
03/14/2013 | US20130064843 Identification of conserved peptide blocks in homologous polypeptides |
03/14/2013 | US20130064842 Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) |
03/14/2013 | US20130064837 Integrin alpha-v beta8 neutralizing antibody |
03/14/2013 | US20130064832 Notch inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof |
03/14/2013 | US20130064826 Anti-emr1 antibodies |
03/14/2013 | US20130064801 Cellular Compositions and Methods of Making and Using Them |
03/14/2013 | US20130064799 Methods for promoting cell reprogramming |
03/14/2013 | US20130064789 Hairy Cell Leukemia Biomarkers and Methods of Using Same |
03/14/2013 | US20130064774 Methods and compositions for maintenance of a functional wound |
03/14/2013 | US20130064763 Anti-icam-1 single domain antibody and uses thereof |
03/14/2013 | US20130064762 Methods of detecting and treating cancers using autoantibodies |
03/14/2013 | US20130064735 Reagent kit with in-transit securing means |
03/14/2013 | US20130062221 Disposable sensor for electrochemical detection of hemoglobin |
03/14/2013 | US20130062201 Glucose Sensor Having Titanium Dioxide-Graphene Composite |
03/14/2013 | US20130061656 Method and device for determining greenhouse gas, in particular methane, emitted by a ruminant, in particular a dairy animal |
03/14/2013 | DE102012215672A1 Test reagent, useful for a rapid assay for protein determination in biological liquids, preferably in urine, comprises reagent mixture containing citric acid, hydrochloric acid and sodium chloride, and reagent vessel |
03/14/2013 | DE102012210085B3 Test station i.e. calibration station, for portable gas measuring device that is worn by user in field exposed to harmful gases, has seal fixed at plastic seal carrier, which is releasably attached on swingable flap |
03/14/2013 | DE102012203717A1 Method for determining thermal property of glass ceramic substrate for extreme UV mirror, involves measuring phase ratio between amorphous phase and crystalline phase of substrate, through X-ray diffraction or Raman spectroscopy |
03/14/2013 | DE102011113302B3 Verfahren und Vorrichtung zur Untersuchung der Fließeigenschaften und der Viskosität von heterogenen flüssigen Stoffen, insbesondere bei Temperaturen von 1000°C und mehr Method and apparatus for investigating the flow characteristics and the viscosity of heterogeneous liquid materials, in particular at temperatures of 1000 ° C and more |
03/14/2013 | DE102011113209A1 Electronic microchip useful in gene sequencing according to sequencing-by-synthesis principle, comprises several wells on its surface that serves as reaction vessels, where electrical conductivity in each individual well is measured |
03/14/2013 | DE102011112638A1 Microfluidic chip used for in-vitro simulation of biological processes in small blood vessels during extravasation of tumor cells from human body, has microfluidic channel system including horizontal channel and horizontal chamber |
03/14/2013 | DE102011082674A1 Method for determining change time of resource e.g. hydraulic fluid in e.g. transmission device of vehicle, involves varying current temperatures of operating device based on current operating conditions |
03/14/2013 | DE102011053541A1 Chemical marker useful for binding to purified biomolecule e.g. antibodies binds to human epidermal growth factor receptor 2 in breast cancer cells, comprises dendrimer comprising chromophores and reactive coupling group |
03/14/2013 | DE102010042043B4 Verfahren und Einrichtung zur nichtinvasiven Bestimmung der epidermalen Barriere der menschlichen Haut Method and apparatus for non-invasive determination of the epidermal barrier of human skin |
03/14/2013 | CA2848359A1 Cellular uptake control systems |
03/14/2013 | CA2847891A1 Methods of increasing the number of target cells recovered from a fluid sample |
03/14/2013 | CA2847847A1 A method of preparing biological material |
03/14/2013 | CA2847839A1 Diagnostic assay to predict cardiovascular risk |
03/14/2013 | CA2847557A1 Method for establishing the presence of specified characteristics of a container product and device for performing said method |
03/14/2013 | CA2847245A1 Use of c-met protein for predicting the efficacy of anti-hepatocyte growth factor ("hgf") antibodies in esophageal and gastric cancer patients |
03/14/2013 | CA2846295A1 Products and methods |
03/14/2013 | CA2844270A1 L-fabp based diagnosis of kidney injury after an acute event or after a surgical intervention |
03/14/2013 | CA2780446A1 Suspension extraction device |